165 related articles for article (PubMed ID: 29794412)
21. Rationale of decreasing low-density lipoprotein cholesterol below 70 mg/dL in patients with coronary artery disease: A retrospective virtual histology-intravascular ultrasound study.
Seo YH; Seo DJ; Song IG; Kim KH; Kwon TG; Bae JH
Cardiol J; 2018; 25(6):674-682. PubMed ID: 29341060
[TBL] [Abstract][Full Text] [Related]
22. Serum Low-Density Lipoprotein Cholesterol Level After Endovascular Therapy in Patients With Claudication.
Tomoi Y; Yamaji K; Soga Y; Hiramori S; Ando K
J Endovasc Ther; 2019 Jun; 26(3):402-410. PubMed ID: 30873910
[TBL] [Abstract][Full Text] [Related]
23. Assessment of Low LDL Cholesterol in Patients Treated by PCSK9 Inhibition: Comparison of Martin/Hopkins and Friedewald Estimations.
Egbaria A; Saliba W; Zafrir B
Cardiovasc Drugs Ther; 2021 Aug; 35(4):787-792. PubMed ID: 33226544
[TBL] [Abstract][Full Text] [Related]
24. Validation of the Estimation of Low-density Lipoprotein Cholesterol by the Modified Friedewald Equation in Ethnic Chinese Adults Living in Taiwan.
Huey-Jen Hsu S; Chen MF; Chen DR; Su TC
Intern Med; 2015; 54(18):2291-7. PubMed ID: 26370851
[TBL] [Abstract][Full Text] [Related]
25. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
26. Does Lowering Low-Density Lipoprotein Cholesterol With Statin Restore Low Risk in Middle-Aged Adults? Analysis of the Observational MESA Study.
Liu K; Wilkins JT; Colangelo LA; Lloyd-Jones DM
J Am Heart Assoc; 2021 Jun; 10(11):e019695. PubMed ID: 33998284
[TBL] [Abstract][Full Text] [Related]
27. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
Mora S; Glynn RJ; Boekholdt SM; Nordestgaard BG; Kastelein JJ; Ridker PM
J Am Coll Cardiol; 2012 Apr; 59(17):1521-8. PubMed ID: 22516441
[TBL] [Abstract][Full Text] [Related]
28. Comparison of cardiovascular disease risk associated with 3 lipid measures in Japanese adults.
Takeuchi T; Nemoto K; Takahashi O; Urayama KY; Deshpande GA; Izumo H
J Clin Lipidol; 2014; 8(5):501-9. PubMed ID: 25234563
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of low-density lipoprotein cholesterol equations by cross-platform assessment of accuracy-based EQA data against SI-traceable reference value.
Tan HT; Yong S; Liu H; Liu Q; Teo TL; Sethi SK
Clin Chem Lab Med; 2023 Sep; 61(10):1808-1819. PubMed ID: 37013650
[TBL] [Abstract][Full Text] [Related]
30. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
[TBL] [Abstract][Full Text] [Related]
31. Comparative performance of equations to estimate low-density lipoprotein cholesterol levels and cardiovascular disease incidence: The ATTICA study (2002-2022).
Nomikos T; Georgoulis M; Chrysohoou C; Damigou E; Barkas F; Skoumas I; Liberopoulos E; Pitsavos C; Tsioufis C; Sfikakis PP; Tselepis A; Panagiotakos DB
Lipids; 2023 Jul; 58(4):159-170. PubMed ID: 37153959
[TBL] [Abstract][Full Text] [Related]
32. Impact of glucose and lipid markers on the correlation of calculated and enzymatic measured low-density lipoprotein cholesterol in diabetic patients with coronary artery disease.
Dong QT; Gao Y; Wu NQ; Guo YL; Zhu CG; Li S; Liu HH; Cao YX; Zhang HW; Zhao X; Liu G; Dong Q; Li JJ
J Clin Lab Anal; 2018 Jun; 32(5):e22399. PubMed ID: 29380428
[TBL] [Abstract][Full Text] [Related]
33. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
[TBL] [Abstract][Full Text] [Related]
34. Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group.
Wilson PWF; Jacobson TA; Martin SS; Jackson EJ; Le NA; Davidson MH; Vesper HW; Frikke-Schmidt R; Ballantyne CM; Remaley AT
J Clin Lipidol; 2021; 15(5):629-648. PubMed ID: 34802986
[TBL] [Abstract][Full Text] [Related]
35. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
Querton L; Buysschaert M; Hermans MP
J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
[TBL] [Abstract][Full Text] [Related]
36. Validation of the Friedewald formula for the estimation of low density lipoprotein cholesterol in a sub-Saharan African population.
Choukem SP; Manases T; Nda-Mefoo JP; Dimala CA; Mboue-Djieka Y; Sobngwi E; Kengne AP
Clin Biochem; 2018 Mar; 53():25-30. PubMed ID: 29273329
[TBL] [Abstract][Full Text] [Related]
37. Validation of the Martin Method for Estimating Low-Density Lipoprotein Cholesterol Levels in Korean Adults: Findings from the Korea National Health and Nutrition Examination Survey, 2009-2011.
Lee J; Jang S; Son H
PLoS One; 2016; 11(1):e0148147. PubMed ID: 26824910
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.
Toth PP; Foody JM; Tomassini JE; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tunceli K
J Clin Lipidol; 2014; 8(1):107-16. PubMed ID: 24528691
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effectiveness of Martin's equation, Friedewald's equation, and a Novel equation in low-density lipoprotein cholesterol estimation.
Song Y; Lee HS; Baik SJ; Jeon S; Han D; Choi SY; Chun EJ; Han HW; Park SH; Sung J; Jung HO; Lee JW; Chang HJ
Sci Rep; 2021 Jun; 11(1):13545. PubMed ID: 34188076
[TBL] [Abstract][Full Text] [Related]
40. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
